Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies

Aaron Burmeister, Daniel Nettersheim|Molecular Cancer Therapeutics|2022

Cited by 25